Navigation Links
Statin Users Suffering from Side Effects Are in the Dark
Date:5/7/2012

PASADENA, Texas, May 7, 2012 /PRNewswire/ -- Experts estimate nearly 30 million Americans, approximately 10 percent of the population, take some form of cholesterol-lowering drug, also known as statins, under brands such as Lipitor®, Zocor®, Pravachol®, and Crestor®. Statins are among the most widely prescribed drugs in the United States and cardiologists agree that they remain the most effective long-term treatment for cholesterol patients in the high-risk category. However, many patients are not aware that through regular statin therapy they may be depleting their bodies of valuable vitamins and nutrients essential for healthy living. The depletion may be associated with an increasing number of side effects exhibited by statin patients – and relief from these side effects is not commonly known.

(Logo: http://photos.prnewswire.com/prnh/20120507/SF00557LOGO)  

In the past, statins have generally been considered to be safe, however, as the population of statin users continues to rapidly increase, statin studies continue to emerge showing that there is also a significant increase in the number of side effects, such as chronic fatigue and muscle pain. In fact, studies show that 10 to 20 percent of patients treated with statins complain of muscle symptoms and in rare instances use may result in serious muscle damage with myositis, inflammation and rhabdomyolysis. Even in the absence of clinically relevant muscle damage a significant number of patients experience an array of symptoms including muscle pain (myalgia), weakness, cramps and fatigue.

"Statins reduce cholesterol production effectively but not selectively – they also block the synthesis of Ubiquinol, a powerful lipid-soluble antioxidant found in every cell in the body that helps to protect the cardiovascular system from oxidative damage and an essential coenzyme required for cellular energy production," explains Dr. Robert Barry, Executive Director of Scientific Affairs at Kaneka Nutrients, the leading manufacturer of Ubiquinol supplements in the United States. The company reports that depletion of Ubiquinol can induce mitochondrial dysfunction by impairing oxidative phosphorylation, energy production and aerobic capacity. Ubiquinol depletion resulting from statin treatment may therefore impair muscle energy metabolism and contribute to the development of myopathy and muscle symptoms.  

Many statin patients are not informed of this sometimes severe side-effect. Statin-related symptoms can affect the quality of life and often result in multiple dose alterations, switching brands of statins and ultimately, non-compliance. Statin patients who take Ubiquinol as a supplement therapy will be replacing the loss of Ubiquinol in the body and giving back what the muscles need to perform.

Talk to your doctor about supplementing your diet with Ubiquinol, sold in most pharmacies and health food stores. Visit Ubiquinol.org to learn more.

About Kaneka Nutrients:
Ubiquinol is manufactured in the USA by Kaneka, the leader in premium CoQ10 ingredients worldwide. Ubiquinol helps sustain the body's natural energy, protect cells from damage, slow the aging process, and promote the overall health of the heart and other vital organs. It is the advanced active form of CoQ10 that is more easily utilized and absorbed in the body. Kaneka was the first company to successfully commercialize CoQ10 and Ubiquinol and has been the single largest supporter of research for more than 30 years. For more information and the latest clinical research on Ubiquinol, please visit www.ubiquinol.org.


'/>"/>
SOURCE Kaneka Nutrients
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. Survey Finds At-Risk Consumers Interested in OTC Statin
4. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
5. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
6. Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
7. New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease
8. RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
9. CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
10. Seniors Can Be Heartened by New Study on Statins
11. New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointestinal Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced it has earned a spot ... 2017" list. The Company was ranked among 500 U.S. ... Employers and Healthcare Equipment and Services. The ... on an anonymous, independent survey of over 30,000 employees ...
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
(Date:5/8/2017)... NEW YORK , May 8, 2017 ... in the transition from fee for service reimbursement. Black ... April 2017. 1.       The Market for ... 77% of physician practices with 3 or ... Compliance Technology Solutions by Q4. "Given the magnitude of ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as ... production of the series is on hiking in American. Viewers can reconnect with America ... great benefits of hiking. , Many consumers have looked for an inventive new place ...
(Date:5/26/2017)... ... ... FAMILY-Our Journey to the Cross”: the personal journey of Bob Massey and his faith in ... authors, Bob and Margaret Massey. Bob Massey is small in stature but big in ... His love for others is apparent in all of his life decisions. , ...
(Date:5/26/2017)... ... ... “Cactus Jack: Against All Odds”: the story of Coach Cactus Jack and the ... is the creation of published author, Walter Hubbard, a retired wildlife and fisheries biologist ... Jane. Walter. Walter and Jane have three adult children and a granddaughter. ...
(Date:5/24/2017)... ... May 24, 2017 , ... In ... choosing the most appropriate instruments for research and understanding the basic principles that ... webinar will focus on innovations in stereo microscopy for brightfield and fluorescence typically ...
(Date:5/24/2017)... ... May 24, 2017 , ... NucleusHealth ™, ... has received U.S. Food and Drug Administration (FDA) 510(k) clearance for ... secure cloud platform for medical image management. At the core is patented streaming ...
Breaking Medicine News(10 mins):